Antabio Awarded $4.4M for Continued Research for CF Lung Infection Therapy
Antabio has received $4.4 million to continue its research for a therapy against Pseudomonas aeruginosa lung infections in people with cystic fibrosis. Click here to learn more.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.